Open access · OA
via Europe PMC
Osteoporosis and Alzheimer's Disease: The Role of Sclerostin.
Gagiano L, Chen Z, Blakeney WG, Jones C, Mastaglia F, Zheng M, Yuan J.
Current osteoporosis reports · 2026
Abstract
<h4>Purpose of review</h4>Little is known about the underlying cause contributing to the association between Osteoporosis (OP) and Alzheimer's disease (AD). This review highlights the emerging role of sclerostin, a protein mainly produced by osteocytes, in the newly discovered crosstalk between bone and brain, with a focus on its potential contribution to the relationship between OP and AD.<h4>Recent findings</h4>Circulating sclerostin levels increase with aging and are positively associated with brain amyloid-β burden in older adults. Studies demonstrate that elevated sclerostin can cross the blood-brain barrier, promote amyloid-β peptide deposition, and impair synaptic plasticity by suppressing Wnt/β-catenin signalling, whereas sclerostin inhibition restores neuronal plasticity and attenuates AD pathology. Sclerostin represents a promising target in the bone-brain interaction pathway. Its dual role as a measurable circulating biomarker and a modifiable component offers new opportunities for early risk assessment and therapeutic repurposing. Future longitudinal and interventional studies are essential to confirm the association between sclerostin and risk of AD, and to clarify whether targeting sclerostin can delay the onset of the disease or modify its trajectory.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s11914-026-00993-y
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
L, G., Z, C., WG, B., C, J., F, M., M, Z., & J., Y. (2026). Osteoporosis and Alzheimer's Disease: The Role of Sclerostin. <em>Current osteoporosis reports</em>. https://doi.org/10.1007/s11914-026-00993-y
Vancouver
L G, Z C, WG B, C J, F M, M Z, et al. Osteoporosis and Alzheimer's Disease: The Role of Sclerostin. Current osteoporosis reports. 2026. doi:10.1007/s11914-026-00993-y.
BibTeX
@article{gagiano2026Osteop,
title = {Osteoporosis and Alzheimer's Disease: The Role of Sclerostin.},
author = {Gagiano L and Chen Z and Blakeney WG and Jones C and Mastaglia F and Zheng M and Yuan J.},
journal = {Current osteoporosis reports},
year = {2026},
doi = {10.1007/s11914-026-00993-y},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
FASEB bioAdvances 2026
Open access · OA
Retrotransposons in Bone and Joint Diseases.
Metabolic brain disease 2026
Citation only
α-Klotho as a central integrative signalling hub in cognitive function and neuroprotection in neurodegenerative diseases.
Degenerative Neurological and Neuromuscular Disease 2026
Open access · CC-BY
Spermidine in Alzheimer’s Disease: Evidence from Animal Models and Human Studies
Journal of Neurochemistry 2006
Open access · OA
REVIEW: Pin1 in Alzheimer's disease
Translational Neurodegeneration 2024
Open access · CC-BY
Emerging role of senescent microglia in brain aging-related neurodegenerative diseases
Annals of the New York Academy of Sciences 2000
Citation only